“Exposure–Response Analysis Demonstrates Response to Tapinarof Is Driven by Local Effects at Sites of Application”. SKIN The Journal of Cutaneous Medicine, vol. 6, no. 6, Nov. 2022, p. s50, https://doi.org/10.25251/skin.6.supp.50.